FindTrial
Sign In

A prospective study of ablation of thyroid papillary carcinoma and cervical lymph node metastasis versus thyroidectomy

Basic and Clinical Application Research on Ultrasound Visualization of Anatomical Structure and Ablation Thermal Field of Thyroid and Neck

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077786
Enrollment
Unknown
Registered
2023-11-20
Start date
2023-11-30
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Papillary Carcinoma

Interventions

Ablation Group:ablation
Thyroidectomy Group:thyroidectomy

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically confirmed papillary thyroid cancer and metastatic lymph nodes 2. Able to tolerate surgery 3. Without distant metastasis

Exclusion criteria

Exclusion criteria: 1. Abnormal coagulation function tests, such as prothrombin time longer than 18 seconds, prothrombin activity lower than 60%, and platelet count less than 60x10^9/L; 2.Intractable complications, such as cardiac insufficiency or hypertension, that could not be controlled with drugs;

Design outcomes

Primary

MeasureTime frame
Tumor progression;—

Secondary

MeasureTime frame
lesion size;The thyroid function;—

Countries

China

Contacts

Public ContactMing'an Yu

China-Japan Friendship Hospital

yma301@163.com+86 150 1069 8109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026